Cannabis Clinical Trials

VAUGHAN, Ontario, July 11, 2018 /PRNewswire/ — The study is designed to evaluate the efficacy of CannTrust’s Cannabidiol Oil Capsules in slowing Amyotrophic Lateral Sclerosis (ALS) progression  CannTrust Holdings Inc. (“CannTrust” or the “Company”) (TSX: TRST), one of Canada’s leading licensed producers of medical cannabis, announced today that it has partnered with Australia’s Gold Coast […]

BERLIN, July 8 (Xinhua) — Post-traumatic stress disorder (PTSD), anxiety and some types of inflammation may be alleviated by cannabis-like drugs, according to a research presented on Sunday at the FENS Forum of Neuroscience held in Berlin. At the Federation of European Neuroscience Societies (FENS) Forum, which will last till Wednesday, research teams from Italy […]

Getty Chemotherapy-induced nausea and vomiting (CINV) is the one of the most serious, unpleasant and even severe adverse effects of cancer treatment. Based on the emetogenic potential, chemotherapeutic drugs are classified as high, moderate or low-risk drugs. However, the risk of developing CINV is anywhere between 70% – 80% in cancer patients. Chemotherapy-administered cancer patients […]

Cannabinoid-based drug developer Zynerba Pharmaceuticals will halt development of its THC prodrug candidate ZYN001 following its failure in a clinical trial, and instead refocus its development effort and investment on CBD permeation-enhanced gel ZYN002. [©Fotolia V] … read more at: https://www.genengnews.com/gen-news-highlights/zynerba-scraps-development-of-thc-prodrug-zyn001-after-failed-trial/81255993

The recent approval of the drug Cannabidiol (CBD) by the US Food and Drug Administration (FDA) is a decision of seismic proportions to the medical cannabis business. The Drug Enforcement Administration (DEA) must now make a determination as to the classification of CBD based on the FDA’s finding of medicinal value for this purified drug […]